Clinical Efficacy and Mechanism of tDCS for Dysphagia in Parkinson's Disease (NCT07153692)

Overview

This study evaluates the efficacy and mechanisms of transcranial direct current stimulation (tDCS) for treating dysphagia (swallowing difficulties) in patients with Parkinson's disease and related disorders["@nct"].

Study Details

| Field | Value |
|-------|-------|
| NCT ID | NCT07153692 |
| Status | Recruiting |
| Phase | To be determined |
| Study Type | Interventional |
| Conditions | Parkinson's Disease, PSP, Atypical Parkinsonism |
| Intervention | Transcranial Direct Current Stimulation (tDCS) |

Scientific Rationale

Overview

This study evaluates the efficacy and mechanisms of transcranial direct current stimulation (tDCS) for treating dysphagia (swallowing difficulties) in patients with Parkinson's disease and related disorders["@nct"].

Study Details

| Field | Value |
|-------|-------|
| NCT ID | NCT07153692 |
| Status | Recruiting |
| Phase | To be determined |
| Study Type | Interventional |
| Conditions | Parkinson's Disease, PSP, Atypical Parkinsonism |
| Intervention | Transcranial Direct Current Stimulation (tDCS) |

Scientific Rationale

Dysphagia in Parkinsonian Syndromes

• PD: Up to 50-80% develop dysphagia
• PSP: Present in majority, especially later stages
• MSA: Early and severe involvement

Consequences

• Aspiration pneumonia (leading cause of death)
• Malnutrition and dehydration
• Reduced quality of life
• Social isolation

tDCS Mechanism

• Non-invasive brain stimulation
• Modulates cortical excitability
• Can enhance neuroplasticity
• Targets swallowing cortex

Target Regions

• Pharyngeal motor cortex
• Premotor cortex
• Brainstem swallowing centers
• Cortical-subcortical networks

Study Objectives

Primary Endpoints

• Swallowing function (videofluoroscopic assessment)
• Penetration-Aspiration Scale scores
• Quality of life measures

Secondary Endpoints

• Cortical activation patterns (fMRI)
• Swallowing kinematics
• Safety and tolerability
• Long-term effects

Intervention Protocol

• Stimulation parameters: 2 mA, 20 min/day
• Session frequency: To be determined
• Duration: Multi-week protocol
• Target: Pharyngeal motor cortex

Relevance to PSP

Dysphagia in PSP is particularly important because:

• Contributes to mortality (aspiration pneumonia)
• Develops early in disease course
• Limited treatment options
• Affects cortical and brainstem structures

• Improved understanding of tDCS mechanisms
• Potential therapeutic application
• Biomarker development

Expected Outcomes

Cross-References

• tDCS in PSP
• Dysphagia in PSP
• Aspiration Pneumonia Prevention
• Non-Invasive Brain Stimulation

References

Additional Background

Neuroanatomy of Swallowing

Swallowing is a complex sensorimotor process requiring coordinated activity across multiple brain regions:

• Cerebral Cortex: Primary motor cortex (M1), premotor cortex, supplementary motor area
• Brainstem: Medulla oblongata (swallowing center), nucleus tractus solitarius
• Cranial Nerves: V, VII, IX, X, XII innervate oropharyngeal structures
• Subcortical Structures: Basal ganglia, cerebellum for motor sequencing

tDCS Mechanisms of Action

Transcranial direct current stimulation modulates neuronal excitability through weak electrical currents (typically 1-2 mA):

• Anodal stimulation: Increases cortical excitability, enhances neuroplasticity
• Cathodal stimulation: Decreases cortical excitability
• Effects on neurotransmission: Modulates glutamate, GABA, and dopamine systems
• Neurotrophic effects: May influence BDNF expression and synaptic plasticity
• Anti-inflammatory effects: Potential modulation of neuroinflammation

Clinical Evidence for tDCS in Parkinson's Disease

Multiple studies have investigated tDCS in PD:

• Motor symptoms: Mixed results; some studies show modest improvement in UPDRS scores
• Cognitive function: Some benefit in executive function and working memory
• Gait: Limited evidence for gait improvement
• Dysphagia: Emerging evidence for swallowing function improvement

tDCS in PSP

Progressive supranuclear palsy presents unique challenges:

• Early and severe dysphagia
• Cortical and subcortical involvement
• Limited pharmacological treatment options

• Modulation of dysfunctional cortical-subcortical networks
• Potential neuroprotective effects
• Adjunct to pharmacological therapy

Technical Considerations

Stimulation Parameters

• Current intensity: 1-2 mA typically used
• Session duration: 10-30 minutes
• Number of sessions: Typically 5-20 sessions
• Electrode placement: Various montages (bipolar, unilateral, bilateral)

Safety Profile

• Transient skin irritation
• Mild headache
• Rare: seizure risk minimal with standard protocols

Future Directions

Biomarker Development

• fMRI to assess cortical activation changes
• MEG/EEG for network connectivity analysis
• Behavioral measures for functional improvement

Combined Approaches

• tDCS + rehabilitation therapy
• tDCS + pharmacological intervention
• tDCS + other neuromodulation (rTMS)

Comparison with Other Neuromodulation Approaches

| Modality | Mechanism | Invasiveness | Evidence Level |
|----------|-----------|--------------|----------------|
| tDCS | Weak DC current | Non-invasive | Growing |
| rTMS | Magnetic induction | Non-invasive | Moderate |
| DBS | Electrical implant | Invasive | Strong |
| VNS | Vagal stimulation | Invasive/Implant | Growing |

Regulatory Status

• tDCS is FDA-cleared for depression (not specifically for neurological conditions)
• Off-label use for neurological conditions is common
• Clinical trials needed for specific indications like PD dysphagia

References for Expanded Content

Detailed Swallowing Physiology

The Four Phases of Swallowing

• Food is chewed and mixed with saliva
• Formation of bolus
• Tongue manipulates bolus
• Voluntary control

• Tongue propels bolus posteriorly
• Triggered by sensory input
• Duration: ~1 second
• Voluntary to involuntary transition

• Reflexive response
• Elevation of larynx
• Closure of airway
• Opening of upper esophageal sphincter
• Duration: ~1 second

• Peristaltic wave
• Lower esophageal sphincter opens
• Bolus enters stomach
• Duration: 8-20 seconds

Neural Control in Parkinson's Disease

PD affects swallowing at multiple levels:

Cortical Changes:

• Reduced activation in motor and premotor cortex
• Impaired cortical control of swallowing
• Loss of compensatory activation patterns

• Basal ganglia dysfunction affects motor sequencing
• Dopaminergic degeneration impacts swallow timing
• Reduced automaticity of swallowing

• Degeneration of nucleus tractus solitarius
• Dysfunction of swallowing center
• Impaired reflex coordination

Clinical Assessment Tools

Videofluoroscopic Swallowing Study (VFSS)

• Gold standard for dysphagia assessment
• Real-time X-ray imaging
• Visualizes all phases of swallowing
• Penetration-Aspiration Scale (PAS) scoring

Fiberoptic Endoscopic Evaluation of FEES

• Direct visualization of pharynx
• No radiation exposure
• Assessment of secretion management
• Sensory testing capability

Clinical Bedside Assessment

• Water swallow test
• Volume-viscosity assessment
• Standardized clinical scales
• Swallowing frequency monitoring

Pathophysiology of Dysphagia in Parkinsonian Syndromes

Parkinson's Disease

• Levodopa-responsive but dysphagia often persists
• May worsen with disease progression
• Often silent until advanced stages
• Involvement of dopaminergic and non-dopaminergic pathways

Progressive Supranuclear Palsy

• Early and prominent dysphagia
• Vertical gaze palsy association
• Pseudobulbar features
• Rapid progression

Multiple System Atrophy

• Autonomic dysfunction prominent
• Early swallowing involvement
• Respiratory dysfunction overlap
• Poor prognosis

Therapeutic Approaches

Pharmacological

• Levodopa: Variable effects on dysphagia
• Dopamine agonists: Limited benefit
• Botulinum toxin: For cricopharyngeal dysfunction

Rehabilitation

• Swallowing therapy (Lee Silverman Voice Treatment)
• Expiratory muscle strength training
• Mendelssohn maneuver
• Chin-tuck positioning

Neuromodulation

• tDCS: Non-invasive, targets cortical networks
• rTMS: May improve swallow function
• Pharyngeal electrical stimulation

Study Design Considerations

Outcome Measures

• Primary: VFSS parameters, PAS scores
• Secondary: Quality of life (SWAL-QOL), functional oral intake
• Exploratory: Cortical activation (fMRI), biomarkers

Inclusion Criteria

• Diagnosis of PD, PSP, or related disorder
• Clinically significant dysphagia
• Stable medication regimen
• Able to undergo neuroimaging

Exclusion Criteria

• Contraindications to tDCS
• Significant cognitive impairment
• Metallic implants
• Active neurological conditions